These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38467640)

  • 61. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in
    Cooray S; Price-Kuehne F; Hong Y; Omoyinmi E; Burleigh A; Gilmour KC; Ahmad B; Choi S; Bahar MW; Torpiano P; Gagunashvili A; Jensen B; Bellos E; Sancho-Shimizu V; Herberg JA; Mankad K; Kumar A; Kaliakatsos M; Worth AJJ; Eleftheriou D; Whittaker E; Brogan PA
    Front Immunol; 2023; 14():1231749. PubMed ID: 37744344
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
    Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE
    J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432
    [TBL] [Abstract][Full Text] [Related]  

  • 63. USP13-mediated IRAK4 deubiquitination disrupts the pathological symptoms of lipopolysaccharides-induced sepsis.
    Wang Z; Jiang L; Zhang D; Chen D; Wang L; Xiao D
    Microbes Infect; 2021; 23(9-10):104867. PubMed ID: 34298177
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein Degradation.
    Zhang J; Fu L; Shen B; Liu Y; Wang W; Cai X; Kong L; Yan Y; Meng R; Zhang Z; Chen YP; Liu Q; Wan ZK; Zhou T; Wang X; Gavine P; Del Rosario A; Ahn K; Philippar U; Attar R; Yang J; Xu Y; Edwards JP; Dai X
    Cell Chem Biol; 2020 Dec; 27(12):1500-1509.e13. PubMed ID: 32888499
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12).
    Patel S; Harris SF; Gibbons P; Deshmukh G; Gustafson A; Kellar T; Lin H; Liu X; Liu Y; Liu Y; Ma C; Scearce-Levie K; Ghosh AS; Shin YG; Solanoy H; Wang J; Wang B; Yin J; Siu M; Lewcock JW
    J Med Chem; 2015 Oct; 58(20):8182-99. PubMed ID: 26431428
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors.
    Seganish WM; Fischmann TO; Sherborne B; Matasi J; Lavey B; McElroy WT; Tulshian D; Tata J; Sondey C; Garlisi CG; Devito K; Fossetta J; Lundell D; Niu X
    ACS Med Chem Lett; 2015 Aug; 6(8):942-7. PubMed ID: 26288698
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 Inhibitors.
    Bolduc PN; Pfaffenbach M; Evans R; Xin Z; Henry KL; Gao F; Fang T; Silbereis J; Vera Rebollar J; Li P; Chodaparambil JV; Metrick C; Peterson EA
    ACS Med Chem Lett; 2024 May; 15(5):714-721. PubMed ID: 38746903
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of IRAK4 Inhibitors
    Bothe U; Günther J; Nubbemeyer R; Siebeneicher H; Ring S; Bömer U; Peters M; Rausch A; Denner K; Himmel H; Sutter A; Terebesi I; Lange M; Wengner AM; Guimond N; Thaler T; Platzek J; Eberspächer U; Schäfer M; Steuber H; Zollner TM; Steinmeyer A; Schmidt N
    J Med Chem; 2024 Jan; 67(2):1225-1242. PubMed ID: 38228402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery of 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2s,3S,5S,7S)-5-hydroxyadamantan-2-yl)pyrimidine-4-carboxamide (SKI2852): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1).
    Ryu JH; Lee JA; Kim S; Shin YA; Yang J; Han HY; Son HJ; Kim YH; Sa JH; Kim JS; Lee J; Lee J; Park HG
    J Med Chem; 2016 Nov; 59(22):10176-10189. PubMed ID: 27798827
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway.
    Shi M; Deng Y; Yu H; Xu L; Shi C; Chen J; Li G; Du Y; Wang YG
    Mediators Inflamm; 2019; 2019():7634761. PubMed ID: 31611735
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
    Somani VK; Zhang D; Dodhiawala PB; Lander VE; Liu X; Kang LI; Chen HP; Knolhoff BL; Li L; Grierson PM; Ruzinova MB; DeNardo DG; Lim KH
    Gastroenterology; 2022 Jun; 162(7):2047-2062. PubMed ID: 35271824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design and synthesis of novel indole and indazole-piperazine pyrimidine derivatives with anti-inflammatory and neuroprotective activities for ischemic stroke treatment.
    Wang H; Cui E; Li J; Ma X; Jiang X; Du S; Qian S; Du L
    Eur J Med Chem; 2022 Nov; 241():114597. PubMed ID: 35931005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.
    Giménez N; Schulz R; Higashi M; Aymerich M; Villamor N; Delgado J; Juan M; López-Guerra M; Campo E; Rosich L; Seiffert M; Colomer D
    Leukemia; 2020 Jan; 34(1):100-114. PubMed ID: 31197259
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
    Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
    Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
    Zhang D; Li L; Jiang H; Knolhoff BL; Lockhart AC; Wang-Gillam A; DeNardo DG; Ruzinova MB; Lim KH
    Clin Cancer Res; 2017 Apr; 23(7):1748-1759. PubMed ID: 27702822
    [No Abstract]   [Full Text] [Related]  

  • 77. Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88
    Degorce SL; Anjum R; Bloecher A; Carbajo RJ; Dillman KS; Drew L; Halsall CT; Lenz EM; Lindsay NA; Mayo MF; Pink JH; Robb GR; Rosen A; Scott JS; Xue Y
    J Med Chem; 2019 Nov; 62(21):9918-9930. PubMed ID: 31622099
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
    Celhar T; Lu HK; Benso L; Rakhilina L; Lee HY; Tripathi S; Zharkova O; Ong WY; Yasuga H; Au B; Marlier D; Lim LHK; Thamboo TP; Mudgett JS; Mackey MF; Zaller DM; Connolly JE; Fairhurst AM
    Front Immunol; 2019; 10():1546. PubMed ID: 31354711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitor.
    Finlay HJ; Lloyd J; Vaccaro W; Kover A; Yan L; Bhave G; Prol J; Huynh T; Bhandaru R; Caringal Y; DiMarco J; Gan J; Harper T; Huang C; Conder ML; Sun H; Levesque P; Blanar M; Atwal K; Wexler R
    J Med Chem; 2012 Apr; 55(7):3036-48. PubMed ID: 22409629
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
    Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
    J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.